LSI Director, Dr. Pieter Cullis is a strong believer in supporting our graduate students and post docs in their career pursuits and in creating new opportunities in order to retain the research knowledge and expertise amongst our top trainees and graduates. Under his leadership, there now exist a number of new opportunities.
We have many examples of successful life scientists who are also entrepreneurs in their own right. The LSI has a unique approach to commercializing innovations as it is not just the technologies that we focus on, rather we foster the spirit of commercialization, of providing career advancement of our post docs and graduate students. Numerous LSI graduates and post docs are currently CEOs of the companies founded by their PIs. By partnering with other UBC units, LSI offers comprehensive insight and support to our members who wish to start their own company. Please visit our commercialization section for more information and contact our Business Development team if you have a research expertise and would like to pursue commercialization.
LSI Personalized Medicine Projects
The LSI has formed more than 10 major projects in collaboration with leading clinicians that are aimed at changing clinical practice through the introduction of improved diagnostics to guide therapy. These projects, which are accessing non-traditional funding sources such as pharmaceutical companies, philanthropy and the healthcare system, have objectives of improving cancer care, drug prescription practices, diagnosis and treatment of autism, diabetes care, and diagnostics to guide cardiovascular therapy among others. For more information, please take a look at our Personalized Medicine Projects and contact the LSI Staff if you would like to get involved.
“Cameron Strachan, CEO and co-founder of MetaMixis inc., is passionate about synthetic biology. After graduating top student in microbiology at UBC, he worked to develop technologies for high-throughput genetic engineering. He then, alongwith Professor Steven Hallam from LSI, co-founded MetaMixis Inc., which engineers bacteria from the products of renewable specialty chemicals. Cameron is now working to grow MetaMixis and hopes the company will one day have a dramatic impact on sustainable manufacturing.” Metamixis has been selected to participate in the Canadian Technology Accelerator (CTA) in San Francisco and Silicon Valley, managed by the Canadian Trade Commissioner Services. Cameron is using this opportunity to engage companies in California, and potentially bring some of the collaborations back to Canada.”
– Cameron Strachan | CEO and co-founder of MetaMixis inc.